跳至主要内容
临床试验/NCT05431530
NCT05431530招募中不适用

Assessment of Quality of Life After Low Anterior Resection or Visceral Peritoneal Stripping During cytOreDuctive surgerY for Advanced Ovarian Cancer Requiring Tumor Resection on the Rectosigmoid Colon: a Prospective Cohort Study

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2022年6月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
108
试验地点
1
主要终点
Frequency of major LARS after surgery

研究概览

简要总结

This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.

详细描述

In advanced ovarian cancer, 24-64% of patients require removal of tumors located in the rectum and sigmoid colon. In order to remove the tumor located in the rectum and sigmoid colon, low anterior resection (LAR) is performed to excise the rectum and sigmoid colon. All patients who underwent low anterior resection are at risk of developing low anterior resection syndrome, which presents symptoms such as frequent bowel movements, frequent defecation, and impaired stool control. Therefore, this study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Those with newly diagnosed ovarian cancer, fallopian tube cancer and primary peritoneal carcinomatosis who plan to undergo cytoreductive surgery and secondary cytoreductive surgery after neoadjuvant chemotherapy.
  • Patients with PCDS or rectal and sigmoid coloni tumor invasion suspected on the preoperative image and need resection of the tumor and clinical FIGO stage IIIB or higher
  • ECOG performance status : 0-2
  • Age over 18

排除标准

  • Patient who underwent low anterior resection in the past
  • Past history of gastrointestinal malignant tumor except to ovarian cancer
  • Patient who have colostomy
  • Patient who underwent radiation therapy to abdominal or pelvic cavity
  • ECOG performance status over 3
  • Patient taking opioid analgesics
  • Patient who have intellectual disability or dementia

结局指标

主要结局

Frequency of major LARS after surgery

时间窗: 12 months after LAR implementation

Frequency of major LARS (corresponding to 30-42 points as a result of LARS questionnaire) 12 months after LAR implementation

次要结局

  • EORTC QLQ-Ov28(2weeks before surgery, 6,12,24 months after surgery)
  • Bristol stool form scale(2weeks before surgery, 2weeks after surgery(before adjuvant chemotherapy), 3,6,12,24 months after surgery)
  • Incidence of major, minor LARS after visceral peritoneal stripping(2weeks after surgery)
  • LARS severity(2weeks before surgery, 2weeks after surgery(before adjuvant chemotherapy), 3,6,12,24 months after surgery)
  • The fecal incontinency quality of life scale(FIQL)(2weeks before surgery, 2weeks after surgery(before adjuvant chemotherapy), 3,6,12,24 months after surgery)
  • EOTC QLQ-C30(2weeks before surgery, 6,12,24 months after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验